Skip to main navigation Skip to search Skip to main content

Stomatococcus mucilaginosus: An Emerging Pathogen in Neutropenic Patients

P. H.M. McWhinney*, C. C. Kibbler, S. H. Gillespie, S. Patel, D. Morrison, A. V. Hoffbrand, H. G. Prentice

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Stomatococcus mucilaginosus was isolated from eight neutropenic patients during nine febrile episodes over a 13-month period. Five of these isolates were from definite infections, including one case of fatal meningitis. This slime-producing, catalase-variable, gram-positive coccus is a component of the normal oral flora of humans. Its biochemical profile may result in misidentifica- tion; however, unlike most micrococci, it characteristically fails to grow on media containing 5% NaCl. All but one of our isolates were sensitive to benzylpenicillin, and all were sensitive to vancomycin. S. mucilaginosus may prove to be an important pathogen in severely immunocompromised patients.

Original languageEnglish
Pages (from-to)641-646
Number of pages6
JournalClinical Infectious Diseases
Volume14
Issue number3
DOIs
Publication statusPublished - 1 Mar 1992

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Stomatococcus mucilaginosus: An Emerging Pathogen in Neutropenic Patients'. Together they form a unique fingerprint.

Cite this